Agenda: Seattle Biotech Seizes the Momentum

 

Join us at Xconomy Forum: Seattle Biotech Seizes the Momentum on May 6
5.6.2015  AGENDA
 .
1:30 – 2:30 Registration & Networking
2:30 – 2:40 Welcome & Opening Remarks
Gary Gilliland, President & Director, Fred Hutchinson Cancer Research Center
Jim Edwards, Publisher, Xconomy
2:40 – 3:00 Fred Hutchinson Steps Towards Cures
Gary Gilliland, Fred Hutchinson Cancer Research Center
Alex Lash, National Biotech Editor, Xconomy
3:00 – 3:30 Innovation’s Source: Seattle’s Nonprofit and Academic Core
Gary Gilliland, Fred Hutchinson Cancer Research Center
Charlotte Hubbert, Program Investment Officer, The Bill & Melinda Gates Foundation
Vikram Jandhyala, Vice Provost for Innovation, CoMotion
David Poston, COO, Allen Institute
Alex Lash, National Biotech Editor, Xconomy (Moderator)
3:30 – 3:50 T-Cell Therapies Hit The Clinic (Cancer Immunotherapy, Part 1)
Hans Bishop, CEO, Juno Therapeutics
Carlos Paya, CEO, Immune Design
3:50 – 4:20 Local for the Long Haul: Building Seattle’s Anchor Biotechs
Eric Dobmeier, COO, Seattle Genetics
Heather Franklin, CEO, Blaze Bioscience
Randy Schatzman, CEO, Alder Biotherapeutics
Mike Gallatin, Senior Advisor, Frazier Healthcare (Moderator)
4:20 – 4:45 Networking Break
4:45 – 5:00 Adaptive Bulks Up (Cancer Immunotherapy, Part 2)
Chad Robins, CEO, Adaptive Biotechnologies
5:00 – 5:25 Square-Off: Biotech vs. Tech (But Also, Biotech + Tech)
Robert Nelsen, Managing Director, ARCH Venture Partners
Matt Mcllwain, Managing Director, Madrona Venture Group
5:25 – 5:45 21st Century Wellness, and How to Get There
Lee Hood, President, The Institute for Systems Biology
Alex Lash, National Biotech Editor, Xconomy
5:45 – 6:45 Networking Reception

REGISTER NOW: xconomyforum75.eventbrite.com

*Speakers and program schedule are subject to change.